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Abstract 
The interactions of catechol (substrate), 2-hydroxy-pyridine-N-oxide (substrate analogue), and 2-bromophenol (inhibitor) with the extradiol 
cleaving catechol-2,3-dioxygenase from Pseudomonasputida mt-2 have been monitored through X-ray absorption spectroscopy (XAS). The analysis 
of the data provides details about the mode of coordination of the substrate and of the inhibitors to the active site of the enzyme. 
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1. Introduction 
Catechol-2,3-dioxygenase (hereafter C2,30) provides 
a critical step in the biodegradation pathways of a large 
share of environmental aromatic pollutants by catalyz- 
ing the extradiol opening of catechol rings and the inser- 
tion of molecular oxygen [ 1,2]. 
Such enzyme is encoded by the xylE gene of the TOL 
plasmid (pWW0) present in the bacterium Pseudomonas 
putida mt-2 [3,4]. Each of the four identical subunits 
(m.wt. 32,000) composing the enzyme contains one high 
spin iron(I1) ion essential for activity. 
Although this enzyme was isolated and crystallized for 
the first time in the early sixties [l&8], the structure of 
the active site is still unclear. No crystallographic data 
are available so far and Mijssbauer spectroscopy has 
given very limited structural information, only suggest- 
ing that catechol binding does not alter the coordination 
environment of the high spin iron(I1) ion [9]. 
Optical absorption, circular dichroism and magnetic 
circular dichroism techniques have also been applied 
proposing a five coordinate structure for iron(I1) in the 
native enzyme and bidentate binding of catechol in the 
enzyme substrate adduct [8]. 
Further information has been obtained by studying 
through EPR, the inactive nitric oxide-enzyme com- 
plexes, which are characterized by a more easily EPR 
detectable S = 312 spin state. Hyperfine broadening of 
the EPR resonances of the nitrosyl complexes by “O- 
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enriched H,O showed that water is bound to iron and it 
is displaced by substrates [6]. 
In our laboratory we have approached the problem of 
the structural characterization of the active site of this 
enzyme through XAS and NMR spectroscopies. 
‘H NMR data on the interaction of ortho-substituted 
phenols and aliphatic ketones were collected in order to 
obtain information on inhibitor-enzyme complexes. 
TiM-’ (i = 1,2) paramagnetic enhancements o the relaxa- 
tion rates are consistent with the direct binding of such 
compounds to the paramagnetic iron(I1) center [lo]. 
Previous XAS studies allowed us to reveal two histid- 
ines bound to the metal ion. Additional oxygen/nitrogen 
ligands complete the coordination sphere. The intensity 
of the pre-edge absorption has been suggested to be in- 
dicative of the coordination number. By comparison 
with the available data, the pre-edge absorption intensity 
is consistent with hexacoordination. Furthermore the 
metal geometry does not appear to be significantly af- 
fected by the binding of the inhibitor 2-chlorophenol 
[l 11. EXAFS studies should not be considered to provide 
unequivocal structural data but as spectroscopic ap- 
proach may be useful in providing structural patterns in 
a series of related systems. 
In the present paper we extend the XAS studies on 
C2,30 to the characterization of the enzyme-substrate 
and enzyme-inhibitor adducts. For this reason we have 
collected XAS spectra of C2,30 in the presence of the 
substrate catechol, of the substrate analogue 2-hydroxy- 
pyridine-N-oxide, and of the inhibitor 2-bromophenol. 
2. Materials and methods 
The Pseudomonas putida bacterial strain mt-2 (ATCC 23973) was 
maintained on a minimal medium having meta-toluate as the exclusive 
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carbon source. Mass cultures and the enzyme purification were per- 
formed as previously described [3,6]. Catechol-2,3-dioxygenase activity 
and concentration were determined as previously reported [lo]. The 
specific activity of the enzyme used in this study was greater than 300 
units/mg. 
r 1 1 , 1 1 1 
X-ray absorption measurements were performed at the EMBL 
EXAFS beamline (c/o DESY, Hamburg), collected and analyzed as 
previously reported [ll]. The data were collected at the iron edge 
(7,122.7 eV at the edge jump inflection point for all samples). The 
spectra were recorded from 6,912 to 7,812 eV with variable step widths. 
All the samples were run as frozen solutions at 20 K. EXAFS sample 
I was composed by a disaerated C2,30 3.5 mM in Fe(H) solution to 
which was anaerobically added a catechol solution up to a final sub- 
strate concentration of 50 mM; sample 2 contained C2,30 3.5 mM in 
Fe(I1) additioned with 7 mM 2-hydroxy-pyridine-N-oxide; sample 3 
contained C2,30 3.5 mM in Fe(I1) plus 35 mM 2-bromophenol. All the 
above reported samples were in 50 mM potassium phosphate buffer, 
pH 7.5, with 10% acetone. A series of 43, 49 and 34 spectra were 
collected for the catechol (sample I), the 2-OH-pyridine-N-oxide (sam- 
ple 2) and the 2-bromophenol (sample 3) complexes respectively. The 
data of sample 3 had to be cut at k = 105 nm-’ because of the presence 
of a discontinuity in the experimental spectrum. The other two data sets 
have been truncated at k = 120 nm-‘. The experimental spectra have 
been matched with the theoretical simulation by adjusting the parame- 
ter dE,,. The values determined were 14.10, 14.36 and 12.15 eV for 
samples 1, 2 and 3 respectively. This resulted in putting the experi- 
mental absorption edge at kz0.18 nm-‘. The above values were kept 
fixed during all subsequent simulations. The energy independent ampli- 
tude reduction factors were determined and kept fixed at 0.71,0.82,0.73 
for samples 1,2 and 3 respectively. The Fourier transforms were calcu- 
lated over the k range 25-120 (105 for sample 3) nm-‘. Gaussian win- 
dows were used for Fourier backtransforms. The distance ranges used 
in the backtransforms are listed in the figures and table captions. 
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Fig. 1. Edge spectra of C2,30 samples: Catechol-C2,30 enzyme com- 
plex (. ,), 2-hydroxy-pyridine-N-oxide-C2,30 enzyme complex 
(-,-.-.- -), 2-bromophenol-C2,30 enzyme complex ( - - - - - -) and (taken 
from [I I]) native C2,30 ( ). 
3. Results 
3.1. Edge data 
The edge position remains constant at 7,122.7 eV for 
all of the three samples. The comparison with the native 
enzyme shows that the iron oxidation state has not 
changed upon ligand binding and that is +2 in every case 
(Fig. 1). A characteristic pre-edge peak appears in the 
iron K-edge spectra at about - 10 eV from the edge. This 
peak is due to a transition to bound states (1 s-3d) which 
is forbidden by the spectral selection rules. Its presence 
can be interpreted in terms of quadrupole and symmetry 
breaking effects [12,13]. The intensity of this transition 
is correlated to the iron coordination geometry [14,15] 
and increases with the deviation from centrosymmetry of 
the complex. The values obtained for the substrate, sub- 
strate-analogue and inhibitor complexes of C2,30 are 
0.043, 0.049 and 0.048 eV respectively. The intensities of 
the ls-3d transition obtained from octahedral ferrous 
model complexes range typically from 0.03 to 0.07 eV 
[l l] whereas the pre-edge peak areas of five coordinate 
Fe(I1) models have been found between 0.089 and 0.107 
eV [15]. Since the intensity for the native enzyme is 0.058 
the present results indicate that the overall symmetry is 
unchanged upon substrate and inhibitor binding and 
that the iron (II) site remains octahedral. 
3.2. EXAFS data 
The filtered k3 weighted experimental EXAFS spectra 
of the three samples are reported for comparison in Fig. 
2. The interaction with the different ligands deeply per- 
turbs the EXAFS spectrum (see [l l] for comparison with 
the native enzyme). This evidence taken together with the 
changes occurring in the XANES region is consistent 
Table 1 
One and two distance fits of the first Fe(H) iron coordination shell of native C2,30 and the catechol, 20H-pyridine-N-oxide, and 2Br-phenol 
complexes with C2,30’ 
Native C2,30* C2,30Catechol complex C2,30-20H-Pyridine-N-oxide C2,30-Bromophenol complex 
complex 
Shell Shell R 2a2x104 Fl Shell Shell R 2~~x10~ Fl Shell Shell R 2~~x10~ Fl Shell Shell R 2a’x104 Fl 
1 2 (nm) (nm’) 1 2 (nm) (rim*) 1 2 (nm) (nm’) 1 2 (nm) (nm’) 
60/N 0.205 2.2 0.1 60/N 0.200 1.8 0.16 60/N 0.201 2.0 0.15 60/N 0.204 1.8 0.46 
40 0.202 1.4 0.05 40 0.197 1.1 0.13 40 0.198 1.2 0.08 40 0.202 1.5 0.42 
2N 0.217 1.5 2N 0.211 0.7 2N 0.213 0.6 2N 0.214 0.7 
30 0.201 0.7 0.09 30 0.196 0.6 0.30 30 0.197 0.6 0.30 30 0.201 0.7 0.49 
2N 0.217 0.4 2N 0.211 0.1 2N 0.213 0.1 2N 0.215 0.2 
’ e.s.d. on distances = & 0.002 nm. ‘Data taken from reference 11. 
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Fig. 2. k3 weighted filtered (between 0.10 and 0.41 nm) (- ) and calculated (- - -) EXAFS spectra with the respective Fourier transforms for 
the (a) Catechol-C2,30 enzyme complex, (b) 2-hydroxy-pyridine-IV-oxide-C2,30 enzyme complex, and (c) 2-bromophenol-C2,30 enzyme complex. 
with the direct binding of the ligands to the iron center. 
The changes mainly affect the iron outer shells atomic 
distribution as shown by the different disposition of the 
outer peaks in the spectra Fourier transforms (FT) (Fig. 
2). 
The features appearing in the EXAFS between 40 and 
65 nm-’ are characteristic of imidazole backscattering. 
The presence of such type of ligands is also revealed in 
the spectra Fourier transforms by the peaks present at 
about 0.28-0.30 and 0.40-0.43 nm. However the differ- 
ent complex peak patterns in the three samples suggest 
that the Fe(I1) ligands have different spatial arrange- 
ments. 
3.3. First shell analysis 
The iron first coordination shell has been analyzed by 
Fourier filtering the nearest neighbours contribution and 
by backtransforming it to k space. The results are re- 
ported in Table 1. Attempts to simulate the first shell 
with a single metal-to-ligand distance have been made 
using five or six O/N atoms. The large values obtained 
for the Debye-Waller factors in every case suggest hat 
a large spread of distances is present in the iron first 
coordination shell; hence two distance fits were per- 
formed. All the possible combinations of oxygen and 
nitrogen atoms summing up to five and six were used. 
The best results are reported in Table 1. The splitting of 
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the Fe-ligand distances in two ranges improves signifi- 
cantly the quality of the fit for the catechol and the 
20H-pyridine-N-oxide complexes. From Table 1 it can 
be seen that the quality of both one- and two-distance fits 
of the 2-bromophenol inhibitor spectrum is not as high 
as that of the other complexes. This is due to the lower 
counting statistics of the sample 3 data and to the shorter 
data range usable. In any case the best results were ob- 
tained with the higher coordination number. 
3.4. Outer shell analysis 
The substrate and inhibitor-enzyme complex forma- 
tion causes remarkable changes in the spectra FT’s outer 
shells peaks distribution with respect to the native en- 
zyme. Variation in the XANES peaks is also observed 
(Fig. 1). 
The peaks in the 0.28-0.43 nm range in the FT of the 
three samples can be due to the presence of histidine 
residues, of the aromatic rings of the substrate/inhibitor 
and to the carbon atoms of the side chains of the other 
iron ligands. In order to estimate the number of histidine 
groups and to monitor the mode of binding of the differ- 
ent exogenous ligands we have performed a multiple 
scattering analysis coupled to constrained refinement on 
spectra Fourier filtered between 0.1 and 0.44 nm. Such 
approach has been proven to be able to account for these 
features both for protein and model compounds data 
[l&19]. Fig. 2 shows that the main features of the spectra 
and of the Fourier transforms of the various substrate/ 
inhibitor-C2,30 complexes could be quite accurately re- 
produced by introducing in the simulation all the atoms 
of two imidazole rings and those of the exogenous ligand 
in addition to the other first shell atoms. 
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Fig. 3. Schemes of the active Iron(I1) coordination sites in: (a) Cat- 
echol-C2,30 enzyme complex, (b) 2-hydroxy-pyridine-N-oxide-C2,30 
enzyme complex, and (c) 2-bromophenol-C2,30 enzyme complex. L 
represents N/O donors. The tram- arrangement of the histidine ligands 
is just a pictorial representation. The water molecule in (c)derives from 
151. 
The complex with the substrate catechol (sample 1) 
was modelled as an iron(I1) bound to two histidine imi- 
dazole nitrogens and four oxygen atoms, two of them 
belonging to the bidentate catechol molecule (see Fig. 
3A). In addition to all the atoms of the two imidazole 
rings two additional shells, corresponding to the two 
C 1 ,C2 and C3, C4 carbon shells of catechol, were added 
to simulate the peaks present in the FT at 0.280 and at 
0.408 nm respectively (see Table 2). The complex with 
the substrate analogue 20H-pyridine-N-oxide (sample 2) 
was designed in a similar way with the analogue molecule 
substituting the catechol as a slightly asymmetric ligand 
(see Fig. 3B). The spectrum was simulated introducing 
the Nl and Cl atoms of the 2-OH-pyridine-N-oxide ring 
at 0.280 and 0.283 nm, respectively, and a further shell 
Table 2 
Parameters used to simulate the Fourier filtered (0.10-0.41 nm) data of catechol, 20H-pyridine-N-oxide, and 2-bromophenol complexes with C2,30 
as reported in the figures’ 
C2,30-Catechol complex C2,30-20H-Pyridine-N-oxide complex C2,30-Bromophenol complex 
FI = 0.80 FI = 0.42 FI = 1.32 
Shell P (nm) 2a* x IO4 (nm’) Shell R (nm) 2a* x lo4 (nm*) Shell R (nm) 2a* x IO4 (nm*) 
40 0.197 1.1 
*2N 0.211 1.0 
2c 0.280 1.8 
*2c 0.299 0.2 
*2c 0.324 1.2 
2c 0.408 1.2 
*2c 0.420 0.2 
*2N 0.429 1.6 
40 0.198 1.3 
*2N 0.213 0.8 
IN 0.280 0.4 
1c 0.283 0.2 
*2c 0.302 0.2 
*2c 0.325 0.6 
2c 0.419 0.8 
*2c 0.422 0.1 
*2N 0.430 1.8 
40 0.202 1.3 
*2N 0.214 0.7 
1C 0.302 1.3 
*2c 0.305 1.4 
*2c 0.327 0.2 
2c 0.380 0.7 
1Br 0.420 1.6 
*2c 0.425 1.5 
*2N 0.433 1.2 
’ c.s.d. on distances = + 0.002 nm. The asterisk refers to the atomic shells describing the imidazole groups. 
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composed by the C2 and C3 atoms of the same molecule 
ring at 0.419 nm (see Table 2). The multiple scattering 
contributions of the catechol and of the 20H-pyridine- 
N-oxide bound bidentate to the iron ion have been calcu- 
lated and found scarcely influencing the spectra simula- 
tions. In the case of the 2-bromophenollenzyme complex 
(sample 3) the monodentate binding of the inhibitor 
through the phenolate oxygen was assumed (see Fig. 
3C). In this case the phenol ring should not contribute 
to multiple scattering effects being tilted of about 11s 
120” with respect o the Fe-O bond and the torsion angle 
Fe- 0-C 1 (phenol)-C2(phenol) being somewhere between 
100” and 120” (i.e. Fe, 0, Cl, C2 not in the same plane). 
These values are observed in the crystal structures of 
Fe(III)-phenolate complexes [20] and of the protein lac- 
toferrin [21]. Indeed such a model, added to the multiple 
scattering contributions from two imidazole rings, is able 
to reproduce all the features of the EXAFS spectrum and 
of its FT. This model also includes one bromine atom at 
0.420 nm, one carbon atom at 0.302 nm accounting for 
the Cl phenolate carbon (superimposed with the imi- 
dazole C2-C5 shells) and a further shell of two carbon 
atoms at 0.380 nm which may account for the phenolate 
C2 and C6 carbons. The peak at 0.42 nm bears contribu- 
tions from the outer imidazole shells and the putative 
bromine atom meaning that our model of monodentate 
binding of the inhibitor is consistent with the experimen- 
tal data. Attempts to simulate the data from samples 1 
and 2 with a monodentate catechol and 2-OH-pyridine 
N-oxide ligands resulted in significantly worse fits and 
were not able to reproduce all the EXAFS features. 
4. Discussion 
The pre-edge peak intensities as well as the EXAFS 
data strongly indicate that the coordination number (six) 
and the geometry remain essentially unchanged in all the 
studied complexes with respect o the native enzyme. As 
the spectral analysis in every case reveals evidences of 
two histidines coordinated to the metal ion, it seems that 
water molecules or other proteic ligands are displaced by 
the substrate/substrate-analogues molecules. Any at- 
tempt to fit the spectra with less than six ligands resulted 
in significantly higher fit indexes and worse visual 
matches. 
A systematic increase in the average first shell distance 
going from the catechol to the 2-hydroxy-pyridine-N- 
oxide and the 2-bromophenol complexes is observed. As 
shown in Table 1, the first shell average distances are 
always shorter than the distances found in the native 
enzyme (reported in Table 1 for comparison), the cat- 
echo1 complex exhibiting the shortest. All the observed 
distances are in the lower limit of the Fe-O and Fe- 
N(His) distances; the same has been observed also in the 
case of the native lipoxygenase [22,23] and isopenicillin- 
211 
N-synthase [15,24]; similar distances have also been 
found in several Fe(I1) model compounds [25-301. 
It must be kept in mind that it is unsafe to draw firm 
conclusions about the configuration of the Fe(I1) ligands 
based solely on the results of the above fitting analysis. 
However it is possible to state that a model containing 
bidentate complexes of the catechol and 2-hydroxy-pyri- 
dine-N-oxide adducts to the active site iron ion is consis- 
tent with the experimental data whereas a monodentate 
model was unable to give satisfactory results. As a matter 
of fact the relative height of the second shell peak cen- 
tered at about 0.3 nm is decreasing from the catechol to 
the 2-hydroxy-pyridine-N-oxide and the 2-bromophenol 
adduct in agreement with the presence of a symmetric 
bidentate catechol ligand, an asymmetric bidentate li- 
gand, and a monodentate ligand, respectively. In fact a 
bidentate catechol will contribute to the EXAFS signals 
with two aromatic carbon atoms at about 0.28 nm 
whereas in the asymmetric 2-hydroxy-pyridine-N-oxide 
ligand this shell will be split into two slightly different 
distances with consequent partially destructive interfer- 
ence and finally in the monodentate binding case we 
expect the contribution of only one carbon at 0.30 nm. 
In Fig. 3 the schemes representing the active site metal 
ion of C2,30 in the presence of substrate or inhibitors 
as appear from the analysis of the XAS data are re- 
ported. Our data appear to be in agreement with the 
Miissbauer data indicating a substitutional variability at 
the metal center without affecting the coordination num- 
ber [9]. Furthermore the present data on the substrate 
and the substrate analogue-C2,30 complexes hould be 
relevant for the elucidation of the catalytic mechanism 
since they point out that the bidentate binding of such 
molecules to the active site iron ion could be an essential 
feature for a productive enzyme-substrate complex for- 
mation in the extradiol cleaving catalytic process. 
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